Citations (124)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (48)
Paola Villa, Valeria Tagliaferri, Inbal Dona Amar, Clelia Cipolla, Fabio Ingravalle, Giovanni Scambia, Walter Ricciardi & Antonio Lanzone. (2020) Local ultra-low-dose estriol gel treatment of vulvo-vaginal atrophy: efficacy and safety of long-term treatment. Gynecological Endocrinology 36:6, pages 535-539.
Read now
Read now
R. B. Natari, T. M. McGuire, P. J. Baker, A. M. Clavarino, K. D. Dingle & S. A. Hollingworth. (2019) Longitudinal impact of the Women’s Health Initiative study on hormone therapy use in Australia. Climacteric 22:5, pages 489-497.
Read now
Read now
R. B. Machado, N. Santana, L. F. Arruda, N. Reggi, A. C. Gandolpho & S. Siani de Moraes. (2015) How can information on the risk of breast cancer and hormone therapy be better understood?. Climacteric 18:4, pages 545-550.
Read now
Read now
L-å. Mattsson, H. e. Ipsen, C-j. Granqvist & M. Kokot-Kierepa. (2015) Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52 weeks of therapy. Climacteric 18:3, pages 419-425.
Read now
Read now
C. Castelo-Branco, J. Davila, M. F. Perelló, A. Peguero, C. Ros, M. J. Martínez-Serrano & J. Balasch. (2014) Long-term effect of hormone therapy on bone in early menopause: vertebral fractures after 20 years. Climacteric 17:4, pages 336-341.
Read now
Read now
. (2014) Abstracts of Posters. Climacteric 17:sup1, pages 48-108.
Read now
Read now
C. von Hagens, P. Schiller, B. Godbillon, J. Osburg, C. Klose, R. Limprecht & T. Strowitzki. (2012) Treating menopausal symptoms with a complex remedy or placebo: a randomized controlled trial. Climacteric 15:4, pages 358-367.
Read now
Read now
T. J. de Villiers & J. C. Stevenson. (2012) The WHI: the effect of hormone replacement therapy on fracture prevention. Climacteric 15:3, pages 263-266.
Read now
Read now
Y. K. Cao, S. F. Zhang, S. E. Zou & X. Xia. (2012) Daidzein improves insulin resistance in ovariectomized rats. Climacteric 16:1, pages 111-116.
Read now
Read now
Adriana Coutinho de Azevedo Guimarães & Fátima Baptista. (2011) Influence of habitual physical activity on the symptoms of climacterium/menopause and the quality of life of middle-aged women. International Journal of Women's Health 3, pages 319-328.
Read now
Read now
H. Kim, S-Y. Ku, J-J. Sung, S H Kim, Y. M. Choi, J. G. Kim & S. Y. Moon. (2011) Association between hormone therapy and nerve conduction study parameters in postmenopausal women. Climacteric 14:4, pages 488-491.
Read now
Read now
S-Q. Lin, L-Z. Sun, J-F. Lin, X. Yang, L-J. Zhang, J. Qiao, Z-H. Wang, Y-X. Xu, Z-A. Xiong, Y-Z. Zhou, M-L. Wang, J. Zhu, S-R. Chen, H. Su, C-S. Yang, S-H. Wang, Y-Z. Zhang & X-J. Dong. (2011) Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women. Climacteric 14:4, pages 472-481.
Read now
Read now
A. H. MacLennan. (2011) HRT in difficult circumstances: are there any absolute contraindications?. Climacteric 14:4, pages 409-417.
Read now
Read now
N. Köşüş, A. Köşüş, N. Ö. Turhan & H. Kurtaran. (2011) Effect of tibolone on audiologic functions in menopausal women. Climacteric 14:2, pages 262-267.
Read now
Read now
. (2011) Climacteric Commentaries. Climacteric 14:1, pages 189-194.
Read now
Read now
M. Gambacciani, G. Rosano, B. Cappagli, A. Pepe, C. Vitale & A. R. Genazzani. (2011) Clinical and metabolic effects of drospirenone–estradiol in menopausal women: a prospective study. Climacteric 14:1, pages 18-24.
Read now
Read now
S. Indhavivadhana, M. Rattanachaiyanont, T. Wongvananurak, M. Kanboon, K. Techatraisak, P. Leerasiri, P. Tanmahasamut & S. Angsuwathana. (2011) Predictors for metabolic syndrome in perimenopausal and postmenopausal Thai women. Climacteric 14:1, pages 58-65.
Read now
Read now
D. W. Sturdee & N. Panay. (2010) Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 13:6, pages 509-522.
Read now
Read now
I. Fistonic, D. Franic, J. Popic, N. Fistonic & A. Maletic. (2010) Adherence with hormone replacement therapy in menopause. Climacteric 13:6, pages 570-577.
Read now
Read now
H. Zang, H. Shi & L. Speroff. (2010) Low-dose hormone therapy in postmenopausal women in China. Climacteric 13:6, pages 544-552.
Read now
Read now
. (2010) Climacteric commentaries. Climacteric 13:5, pages 500-506.
Read now
Read now
R. D. Langer. (2010) On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause. Climacteric 13:4, pages 303-306.
Read now
Read now
K-E. Huang & R. Baber. (2010) Updated clinical recommendations for the use of tibolone in Asian women. Climacteric 13:4, pages 317-327.
Read now
Read now
C. J. Haines & E. Farrell. (2010) Menopause management: a cardiovascular risk-based approach. Climacteric 13:4, pages 328-339.
Read now
Read now
L. S. G. Ulrich, T. Naessen, D. Elia, J. A. Goldstein & M. Eugster-Hausmann. (2010) Endometrial safety of ultra-low-dose Vagifem 10 μg in postmenopausal women with vaginal atrophy. Climacteric 13:3, pages 228-237.
Read now
Read now
M. A. Duzenli, K. Ozdemir, A. Sokmen, K. Gezginc, A. Soylu, C. Celik, B. B. Altunkeser & M. Tokac. (2010) The effects of hormone replacement therapy on myocardial performance in early postmenopausal women. Climacteric 13:2, pages 157-170.
Read now
Read now
MR Davey. (2010) The role of hormone therapy in the treatment of osteoporosis. Journal of Endocrinology, Metabolism and Diabetes of South Africa 15:1, pages 49-51.
Read now
Read now
G. Samsioe & J. Hruska. (2010) Optimal tolerability of ultra-low-dose continuous combined 17β-estradiol and norethisterone acetate: laboratory and safety results. Climacteric 13:1, pages 34-44.
Read now
Read now
Nick Panay & Anna Fenton. (2009) IMS Consensus Statements – ‘What is their role?’. Climacteric 12:5, pages 365-367.
Read now
Read now
M. Gambacciani & A. Pepe. (2009) Vasomotor symptoms and cardiovascular risk. Climacteric 12:sup1, pages 32-35.
Read now
Read now
N. Panay. (2009) Estrogen dose: the cardiovascular impact. Climacteric 12:sup1, pages 91-95.
Read now
Read now
T. J. de Villiers. (2009) Individualized therapy for osteoporosis prevention and treatment in women under 60. Climacteric 12:3, pages 210-212.
Read now
Read now
C. Haines, S. L. Yu, F. Hiemeyer & M. Schaefers. (2009) Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial. Climacteric 12:5, pages 419-426.
Read now
Read now
A. H. MacLennan, T. K. Gill, J. L. Broadbent & A. W. Taylor. (2009) Continuing decline in hormone therapy use: population trends over 17 years. Climacteric 12:2, pages 122-130.
Read now
Read now
H. Honjo & Y. Taketani. (2009) Low-dose estradiol for climacteric symptoms in Japanese women: a randomized, controlled trial. Climacteric 12:4, pages 319-328.
Read now
Read now
Winfried G. Rossmanith & Wiebke Ruebberdt. (2009) What causes hot flushes? The neuroendocrine origin of vasomotor symptoms in the menopause. Gynecological Endocrinology 25:5, pages 303-314.
Read now
Read now
. (2008) Meeting Abstracts of the 12th World Congress on the Menopause. Climacteric 11:sup2, pages 3-304.
Read now
Read now
M. H. Birkhäuser & I. Reinecke. (2008) Current trends in hormone replacement therapy: perceptions and usage. Climacteric 11:3, pages 192-200.
Read now
Read now
M. H. Birkhäuser, M. H. Birkhäuser, N. Panay, D. F. Archer, D. Barlow, H. Burger, M. Gambacciani, S. Goldstein, J. A. Pinkerton & D. W. Sturdee. (2008) Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 11:2, pages 108-123.
Read now
Read now
D. W. Sturdee, D. F. Archer, V. Rakov, E. Lang & on behalf of the CHOICE Study Investigators. (2008) Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women. Climacteric 11:1, pages 63-73.
Read now
Read now
Pierre Mares, Thierry Chevallier, Marie-Christine Micheletti, Jean-Pierre Daurès, Drazen Postruznik & Pia De Reilhac. (2008) Coronary heart disease and HRT in France: MISSION study prospective phase results. Gynecological Endocrinology 24:12, pages 696-700.
Read now
Read now
Michael Mendelsohn. (2008) Hormones and cardiovascular disease. Gynecological Endocrinology 24:9, pages 483-484.
Read now
Read now
Jeanne Leventhal Alexander, Henry Burger, Lorraine Dennerstein, Nancy Fugate Woods, Susan R Davis, Krista Kotz, Julie Van Winkle, Gregg Richardson, Anna Ratka & Bruce Kessel. (2007) Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity. Expert Review of Neurotherapeutics 7:sup1, pages S115-S137.
Read now
Read now
Peter Alexandersen, Morten A Karsdal & Claus Christiansen. (2007) Hormone replacement as the first-line prevention for postmenopausal osteoporosis. Expert Review of Obstetrics & Gynecology 2:5, pages 689-700.
Read now
Read now
R. Sitruk-Ware. (2007) New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation. Climacteric 10:5, pages 358-370.
Read now
Read now
D. H. Barlow. (2007) Osteoporosis guidelines. Climacteric 10:sup2, pages 79-82.
Read now
Read now
Amos Pines, David W. Sturdee, Alastair H. MacLennan, Hermann P. G. Schneider, Henry Burger & Anna Fenton. (2007) The heart of the WHI study: time for hormone therapy policies to be revised. Climacteric 10:4, pages 267-269.
Read now
Read now
Manuel Neves-e-Castro. (2007) When a dream comes through…. Gynecological Endocrinology 23:8, pages 433-435.
Read now
Read now
Articles from other publishers (76)
Rui Martins, Bruno de Sousa & Vítor Rodrigues. (2022) The geography of the age at menopause in central Portugal since the early twentieth century. Scientific Reports 12:1.
Crossref
Crossref
Niki Sadat Afjeh, Priyanka Lamba & Alefiya Eski. (2021) Potential Impact of Exercise-Associated Amenorrhea and Subsequent Estrogen Therapy on Cardiovascular Disease Risk Factors in Pre-Menopausal Athletes: A Research Protocol. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal 5:4, pages 1-13.
Crossref
Crossref
Annabelle Brennan & Martha Hickey. (2021) Management of Early Menopause/Premature Ovarian Insufficiency in Women with or at High Risk of Breast Cancer. Seminars in Reproductive Medicine 38:04/05, pages 309-314.
Crossref
Crossref
Theresa Burkard, Manon Moser, Marlene Rauch, Susan S. JickChristoph R. Meier. (2019) Utilization pattern of hormone therapy in UK general practice between 1996 and 2015: a descriptive study. Menopause 26:7, pages 741-749.
Crossref
Crossref
Ai-jun Sun, Ya-ping Wang, Bei Gu, Ting-ping Zheng, Shou-qing Lin, Wen-pei Bai, Yang Wei, Shao-fen Zhang & Ying Zhang. (2016) A Multi-center, Randomized, Controlled and Open Clinical Trial of Heyan Kuntai Capsule (和颜坤泰胶囊) and Hormone Therapy in Perimenopausal Women. Chinese Journal of Integrative Medicine 24:7, pages 487-493.
Crossref
Crossref
Manuela Cristina Russu & Alexandra Cristina Antonescu. 2018. Sex Hormones in Neurodegenerative Processes and Diseases. Sex Hormones in Neurodegenerative Processes and Diseases.
Ji Hee Jun, Hye Won Lee, Junhua Zhang, Fengwen Yang & Myeong Soo Lee. (2018) Herbal medicine (Danggui Liuhuang decoction) for managing menopausal symptoms. Medicine 97:4, pages e9735.
Crossref
Crossref
Louiza S. Velentzis, Usha Salagame & Karen Canfell. (2017) Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations. BMC Health Services Research 17:1.
Crossref
Crossref
Meena Dayal & Preeti Yadav. (2017) Management of Postmenopausal Vaginal Atrophy: Review of Literature. Journal of SAFOMS 5:1, pages 51-57.
Crossref
Crossref
Ki-Jin Ryu, Hyun-Tae Park, Yong Jin Kim, Kyong Wook Yi, Jung Ho Shin, Jun Young Hur & Tak Kim. (2016) Vasomotor symptoms and osteoporosis in Korean postmenopausal women. Maturitas 87, pages 27-32.
Crossref
Crossref
Stephanie L. Sherman, Emily G. Allen, Jessica B. Spencer & Lawrence M. Nelson. 2016. FXTAS, FXPOI, and Other Premutation Disorders. FXTAS, FXPOI, and Other Premutation Disorders
199
224
.
Supriya Bulchandani, Philip Toozs-Hobson, Tina Verghese & Pallavi Latthe. (2015) Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?. Post Reproductive Health 21:4, pages 141-145.
Crossref
Crossref
D. Tierney, Oxana Palesh & Laura Johnston. (2015) Sexuality, Menopausal Symptoms, and Quality of Life in Premenopausal Women in the First Year Following Hematopoietic Cell Transplantation. Oncology Nursing Forum 42:5, pages 488-497.
Crossref
Crossref
J. Sassarini & M. A. Lumsden. (2015) Oestrogen replacement in postmenopausal women. Age and Ageing 44:4, pages 551-558.
Crossref
Crossref
Sarah E. McBane, Laura M. Borgelt, Kylie N. Barnes, Sarah M. Westberg, Nicole M. Lodise & Martha Stassinos. (2014) Use of Compounded Bioidentical Hormone Therapy in Menopausal Women: An Opinion Statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:4, pages 410-423.
Crossref
Crossref
Gloria Richard-Davis. (2014) Are acupuncture and Chinese herbal medicine effective options for hot flashes?. Menopause 21:1, pages 3-5.
Crossref
Crossref
Mar?a F. Perell?Anna Peguero, Cristina Ros, Mar?a Jos? Mart?nez-Serrano & Camil Castelo-Branco. (2013) Fracturas vertebrales tras tratamiento hormonal en la menopausia: 20 a?os de seguimiento. Progresos de Obstetricia y Ginecolog?a 56:9, pages 462-466.
Crossref
Crossref
Dana Brown, Amy Henneman & Darshana Desai. (2013) Efficacy of Drospirenone-Containing Hormone Replacement Therapy to Reduce Vasomotor Symptoms of Menopause. Pharmacy 1:2, pages 193-203.
Crossref
Crossref
H.-J. Ahrendt & C. Friedrich. 2013. Die Gynäkologie. Die Gynäkologie
1069
1082
.
Tarja Saaresranta, Päivi Polo-Kantola & Olli Polo. 2013. Sleep Disorders in Women. Sleep Disorders in Women
293
324
.
Saima Rafique, Evelina W. Sterling & Lawrence M. Nelson. (2012) A New Approach to Primary Ovarian Insufficiency. Obstetrics and Gynecology Clinics of North America 39:4, pages 567-586.
Crossref
Crossref
Nick Panay. 2012. Dewhurst's Textbook of Obstetrics & Gynaecology. Dewhurst's Textbook of Obstetrics & Gynaecology
553
564
.
Jasmina-Ziva Cerne, Snjezana Frkovic-Grazio & Ksenija Gersak. (2011) Breast Tumor Characteristics in Hormone Replacement Therapy Users. Pathology & Oncology Research 17:4, pages 917-923.
Crossref
Crossref
María‐del‐Carmen Cravioto, Marta Durand‐Carbajal, Luisa Jiménez‐Santana, Pilar Lara‐Reyes, Armando H. Seuc & Jorge Sánchez‐Guerrero. (2011) Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: A randomized, double‐blind, controlled trial. Arthritis Care & Research 63:12, pages 1654-1663.
Crossref
Crossref
MinFang Tao, YinCheng Teng, HongFang Shao, Ping Wu & Edward J. Mills. (2011) Knowledge, Perceptions and Information about Hormone Therapy (HT) among Menopausal Women: A Systematic Review and Meta-Synthesis. PLoS ONE 6:9, pages e24661.
Crossref
Crossref
V.W. Henderson & R.A. Popat. (2011) Effects of endogenous and exogenous estrogen exposures in midlife and late-life women on episodic memory and executive functions. Neuroscience 191, pages 129-138.
Crossref
Crossref
S. V. Yureneva, V. B. Mychka, L. M. Ilyina & S. N. Tolstov. (2011) Cardiovascular risk factors in women and the role of sex hormones. Cardiovascular Therapy and Prevention 10:4, pages 128-135.
Crossref
Crossref
Bart C. J. M. Fauser, Joop S. E. Laven, Basil C. Tarlatzis, Kelle H. Moley, Hilary O. D. Critchley, Robert N. Taylor, Sarah L. Berga, Paul G. Mermelstein, Paul Devroey, Luca Gianaroli, Thomas D’Hooghe, Paolo Vercellini, Lone Hummelshoj, Susan Rubin, Angelique J. Goverde, Vincenzo De Leo & Felice Petraglia. (2011) Sex Steroid Hormones and Reproductive Disorders. Reproductive Sciences 18:8, pages 702-712.
Crossref
Crossref
Sandra A. Tsai, Marcia L. Stefanick & Randall S. Stafford. (2011) Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009. Menopause 18:4, pages 385-392.
Crossref
Crossref
Sovra Whitcroft & Anne Herriot. (2011) Insulin resistance and management of the menopause: a clinical hypothesis in practice. Menopause International 17:1, pages 24-28.
Crossref
Crossref
John C. Stevenson, Gemma Durand, Elke Kahler & Tomasz Perty?ski. (2010) Oral ultra-low dose continuous combined hormone replacement therapy with 0.5mg 17?-oestradiol and 2.5mg dydrogesterone for the treatment of vasomotor symptoms: Results from a double-blind, controlled study. Maturitas 67:3, pages 227-232.
Crossref
Crossref
James Simon, Lila Nachtigall, Lian G. Ulrich, Michaela Eugster-Hausmann & Robert Gut. (2010) Endometrial Safety of Ultra-Low-Dose Estradiol Vaginal Tablets. Obstetrics & Gynecology 116:4, pages 876-883.
Crossref
Crossref
Ling Xu. (2010) How to judge the association of postmenopausal hormone therapy and the risk of breast cancer. Frontiers of Medicine in China 4:3, pages 290-293.
Crossref
Crossref
C. Bergeron, F.F. Nogales, T. Rechberger, T. Tatarchjuk & L. Zipfel. (2010) Ultra low dose continuous combined hormone replacement therapy with 0.5mg 17β-oestradiol and 2.5mg dydrogesterone: Protection of the endometrium and amenorrhoea rate. Maturitas 66:2, pages 201-205.
Crossref
Crossref
Alexandra Rousseau, Annie Robert, Grigoris Gerotziafas, Dahlia Torchin, Faiez Zannad, Karine Lacut, Christian Libersa, Eric Dasque, Jean‐Louis Démolis, Ismail Elalamy & Tabassome Simon. (2010) Effect of two oral doses of 17β‐estradiol associated with dydrogesterone on thrombin generation in healthy menopausal women: a randomized double‐blind placebo‐controlled study. Fundamental & Clinical Pharmacology 24:2, pages 239-245.
Crossref
Crossref
Marianne CanonicoAgnès FournierLaure CarcaillonValérie OliéGeneviève Plu-BureauEmmanuel OgerSylvie MesrineMarie-Christine Boutron-RuaultFrançoise Clavel-ChapelonPierre-Yves Scarabin. (2010) Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism. Arteriosclerosis, Thrombosis, and Vascular Biology 30:2, pages 340-345.
Crossref
Crossref
Lynne T. Shuster, Deborah J. Rhodes, Bobbie S. Gostout, Brandon R. Grossardt & Walter A. Rocca. (2010) Premature menopause or early menopause: Long-term health consequences. Maturitas 65:2, pages 161-166.
Crossref
Crossref
M. Birkäuser. (2010) Depression und ÖstrogeneDepression and estrogens. Gynäkologische Endokrinologie 8:1, pages 82-88.
Crossref
Crossref
Hyoung Moo Park. (2010) Current use of drugs for osteoporosis in Korea. Korean Journal of Obstetrics and Gynecology 53:2, pages 152.
Crossref
Crossref
Jeong Yuen KimJae Hong SangHyoung Moo Park. (2010) The change of hormone therapy in postmenopausal women in Korea before and after women's health initiative study: 2000~2009. Korean Journal of Obstetrics and Gynecology 53:12, pages 1110.
Crossref
Crossref
Susan Reinwald, Loretta P. Mayer, Patricia B. Hoyer, Charles H. Turner, Stephen Barnes & Connie M. Weaver. (2010) A Longitudinal Study of the Effect of Genistein on Bone in Two Different Murine Models of Diminished Estrogen-Producing Capacity. Journal of Osteoporosis 2010, pages 1-14.
Crossref
Crossref
Margaret E. Wierman, Rossella E. Nappi, Nancy Avis, Susan R. Davis, Ferdinand Labrie, Willam Rosner & Jan L. Shifren. (2010) Endocrine Aspects of Women's Sexual Function. The Journal of Sexual Medicine 7:1, pages 561-585.
Crossref
Crossref
Lotta Lindh-Åstrand, Marie Bixo, Angelica Lindén Hirschberg, Inger Sundström-Poromaa & Mats Hammar. (2010) A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms. Menopause 17:1, pages 72-79.
Crossref
Crossref
H. Rozenbaum. (2010) Ménopause. EMC - Endocrinologie - Nutrition 7:4, pages 1-19.
Crossref
Crossref
Amber R. Cooper, Sharon N. Covington & Lawrence M. Nelson. 2010. Amenorrhea. Amenorrhea
55
82
.
Tarja Saaresranta, Päivi Polo-Kantola & Olli Polo. 2010. Clinical Handbook of Insomnia. Clinical Handbook of Insomnia
117
136
.
Augusto Ferrari. (2009) Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. Journal of Obstetrics and Gynaecology Research 35:6, pages 1083-1090.
Crossref
Crossref
V. Shenoy, J.L. Grobe, Y. Qi, A.J. Ferreira, R.A. Fraga-Silva, G. Collamat, E. Bruce & M.J. Katovich. (2009) 17?-Estradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats. Peptides 30:12, pages 2309-2315.
Crossref
Crossref
Alfred O. Mueck, Harald Seeger & Kai-J. Bühling. (2009) Use of dydrogesterone in hormone replacement therapy. Maturitas 65, pages S51-S60.
Crossref
Crossref
Wolfgang Junge, Volker El-Samalouti, Christoph Gerlinger & Matthias Schaefers. (2009) Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: Open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate. European Journal of Obstetrics & Gynecology and Reproductive Biology 147:2, pages 195-200.
Crossref
Crossref
John C. Stevenson, Howard N. Hodis, James H. Pickar & Rogerio A. Lobo. (2009) Coronary heart disease and menopause management: The swinging pendulum of HRT. Atherosclerosis 207:2, pages 336-340.
Crossref
Crossref
Shelley R. Salpeter, Ji Cheng, Lehana Thabane, Nicholas S. Buckley & Edwin E. Salpeter. (2009) Bayesian Meta-analysis of Hormone Therapy and Mortality in Younger Postmenopausal Women. The American Journal of Medicine 122:11, pages 1016-1022.e1.
Crossref
Crossref
E. Anne MacGregor. (2009) Migraine headache in perimenopausal and menopausal women. Current Pain and Headache Reports 13:5, pages 399-403.
Crossref
Crossref
Gabriela Barbaglia, Francesc Macià, Mercè Comas, Maria Sala, Maria del Mar Vernet, Montserrat Casamitjana & Xavier Castells. (2009) Trends in hormone therapy use before and after publication of the Women's Health Initiative trial. Menopause 16:5, pages 1061-1064.
Crossref
Crossref
Alastair H MacLennan. (2009) Evidence-based review of therapies at the menopause. International Journal of Evidence-Based Healthcare 7:2, pages 112-123.
Crossref
Crossref
Rossella E. Nappi & Franco Polatti. (2009) Continuing Medical Education: The Use of Estrogen Therapy in Women's Sexual Functioning (CME). The Journal of Sexual Medicine 6:3, pages 603-616.
Crossref
Crossref
Carolina Sales Vieira, Fábio Vasconcelos Pereira, Marcos Felipe Silva de Sá, Paulo Louzada Júnior, Wellington Paula Martins & Rui Alberto Ferriani. (2009) Tibolone in postmenopausal women with systemic lupus erythematosus: A pilot study. Maturitas 62:3, pages 311-316.
Crossref
Crossref
Chen-Yu Huang, Chong-Yau Fu, Jen-Yu Tseng, Tzay-Shing Yang & Kuan-Chong Chao. (2009) The Effects of Continuous Combined Oral Estradiol and Norethisterone on Pulsatility Index in Internal Carotid and Uterine Arteries in Early Postmenopausal Taiwanese Women—A Preliminary Study. Taiwanese Journal of Obstetrics and Gynecology 48:1, pages 60-64.
Crossref
Crossref
Lawrence M. Nelson. (2009) Primary Ovarian Insufficiency. New England Journal of Medicine 360:6, pages 606-614.
Crossref
Crossref
Tobias Johannes de Villiers. (2009) Bone health and osteoporosis in postmenopausal women. Best Practice & Research Clinical Obstetrics & Gynaecology 23:1, pages 73-85.
Crossref
Crossref
Alastair H. MacLennan. (2009) Hormone replacement therapy: a 2008 perspective. Obstetrics, Gynaecology & Reproductive Medicine 19:1, pages 13-18.
Crossref
Crossref
E. Anne MacGregor. (2008) Headache and hormone replacement therapy in the postmenopausal woman. Current Treatment Options in Neurology 11:1, pages 10-17.
Crossref
Crossref
Olaf Ortmann & Peyman Hadji. 2009. Klinische Endokrinologie für Frauenärzte. Klinische Endokrinologie für Frauenärzte
521
559
.
Kathryn B. Horwitz. (2008) Commentary: The Year in Basic Science: Update of Estrogen Plus Progestin Therapy for Menopausal Hormone Replacement Implicating Stem Cells in the Increased Breast Cancer Risk. Molecular Endocrinology 22:12, pages 2743-2750.
Crossref
Crossref
Débora Vieira Soares, Flávia Lúcia Conceição & Mário Vaisman. (2008) Aspectos diagnósticos e terapêuticos da síndrome de Sheehan. Arquivos Brasileiros de Endocrinologia & Metabologia 52:5, pages 872-878.
Crossref
Crossref
Odd Erik Johansen & Erik Qvigstad. (2008) Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg. Advances in Therapy 25:6, pages 525-551.
Crossref
Crossref
David W. Sturdee. (2008) The menopausal hot flush—Anything new?. Maturitas 60:1, pages 42-49.
Crossref
Crossref
D. Foth. (2008) Nahrungsergänzungsmittel im KlimakteriumDietary supplements during menopause. Gynäkologische Endokrinologie 6:2, pages 76-81.
Crossref
Crossref
G. Emons. (2008) Hormontherapie mit Östrogenen und Gestagenen in der Peri- und PostmenopauseHormone therapy with estrogens and gestagens in peri- and post-menopause. Der Internist 49:5, pages 553-558.
Crossref
Crossref
Jung Gu Kim, Jung Hwa Kim, Dong Ock Lee, Hoon Kim, Ja Yeon Kim, Chang Suk Suh, Seok Hyun Kim & Young Min Choi. (2008) Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor κB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women. Menopause 15:2, pages 357-362.
Crossref
Crossref
Päivi Polo-Kantola. (2008) Dealing with Menopausal Sleep Disturbances. Sleep Medicine Clinics 3:1, pages 121-131.
Crossref
Crossref
D.W. Sturdee. 2008. International Encyclopedia of Public Health. International Encyclopedia of Public Health
335
343
.
E Anne MacGregor. (2007) Migraine, the menopause and hormone replacement therapy: a clinical review. Journal of Family Planning and Reproductive Health Care 33:4, pages 245-249.
Crossref
Crossref
I. Wiegratz & H. Kuhl. (2007) Praxis der Hormontherapie in der Peri- und PostmenopausePractice of peri- and postmenopausal hormone therapy. Gynäkologische Endokrinologie 5:3, pages 141-149.
Crossref
Crossref
A.O. Mueck & H. Seeger. (2007) Kardiovaskuläre Risiken unter HRT in der PostmenopauseCardiovascular risks in postmenopausal women receiving HRT. Gynäkologische Endokrinologie 5:3, pages 120-126.
Crossref
Crossref
Michael E. Mendelsohn & Richard H. Karas. (2007) HRT and the Young at Heart. New England Journal of Medicine 356:25, pages 2639-2641.
Crossref
Crossref